We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
+6.83%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.06B
AUM Growth
+$11.1M
(+1.1%)
Cap. Flow
-$39M
Cap. Flow
% of AUM
-3.69%
Top 10 Holdings %
Top 10 Hldgs %
18.29%
Holding
2,111
New
638
Increased
394
Reduced
467
Closed
537
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$24.5M |
| 2 |
MBLY
Mobileye N.V.
MBLY
|
+$18.6M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$16.5M |
| 4 |
AABA
Altaba Inc
AABA
|
+$16.4M |
| 5 |
NXP Semiconductors
NXPI
|
+$13.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WWAV
The WhiteWave Foods Company
WWAV
|
+$13.3M |
| 2 |
CEB
CEB Inc.
CEB
|
+$11.1M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$9.66M |
| 4 |
T-Mobile US
TMUS
|
+$9.34M |
| 5 |
CHMT
Chemtura Corporation
CHMT
|
+$8.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.22% |
| 2 | Healthcare | 13.36% |
| 3 | Communication Services | 10.32% |
| 4 | Consumer Discretionary | 7.52% |
| 5 | Industrials | 7.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Howard Hughes
HHH
$4.09B
| $316K | 0.03% |
2,696
+525
| +24% | +$62.2K |
|
427
American International
AIG
$41.5B
| $315K | 0.03% |
+5,040
| New | +$313K |
|
|
LLL
428
DELISTED
L3 Technologies, Inc.
LLL
| $313K | 0.03% |
1,874
-7,139
| -79% | -$1.19M |
|
429
Myriad Genetics
MYGN
$307M
| $312K | 0.03% |
12,092
-30,018
| -71% | -$637K |
|
|
ZEUS
430
DELISTED
Olympic Steel
ZEUS
| $311K | 0.03% |
15,982
+5,339
| +50% | +$97.8K |
|
|
KTWO
431
DELISTED
K2M Group Holdings, Inc
KTWO
| $311K | 0.03% |
12,748
+5,005
| +65% | +$111K |
|
432
Ennis
EBF
$564M
| $310K | 0.03% |
16,235
-8,865
| -35% | -$149K |
|
433
SBA Communications
SBAC
$19.6B
| $310K | 0.03% |
+2,300
| New | +$299K |
|
434
Regeneron Pharmaceuticals
REGN
$80.1B
| $306K | 0.03% |
623
+114
| +22% | +$49.9K |
|
435
TETRA Technologies
TTI
$1.29B
| $306K | 0.03% |
109,500
+14,600
| +15% | +$48.5K |
|
|
AKAO
436
DELISTED
Achaogen Inc
AKAO
| $306K | 0.03% |
14,097
+715
| +5% | +$16.3K |
|
|
MEET
437
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $306K | 0.03% |
60,673
+39,827
| +191% | +$207K |
|
438
Allison Transmission
ALSN
$9.69B
| $304K | 0.03% |
8,100
+3,164
| +64% | +$118K |
|
|
VR
439
DELISTED
Validus Hold Ltd
VR
| $303K | 0.03% |
+5,825
| New | +$314K |
|
|
NBIS
440
Nebius Group N.V.
NBIS
$47.2B
| $302K | 0.03% |
11,493
-640
| -5% | -$16.7K |
|
441
National CineMedia
NCMI
$377M
| $300K | 0.03% |
+4,046
| New | +$378K |
|
|
WMAR
442
DELISTED
West Marine Inc
WMAR
| $299K | 0.03% |
23,276
+20,841
| +856% | +$210K |
|
443
Abeona Therapeutics
ABEO
$409M
| $298K | 0.03% |
1,865
+1,685
| +936% | +$230K |
|
444
Cytokinetics
CYTK
$10.4B
| $296K | 0.03% |
24,482
-387
| -2% | -$5.38K |
|
445
iShares MSCI Indonesia ETF
EIDO
$500M
| $296K | 0.03% |
10,869
| – | – |
|
446
Ryder
R
$10.1B
| $294K | 0.03% |
+4,081
| New | +$282K |
|
|
PTR
447
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $293K | 0.03% |
4,780
| – | – |
|
448
Iovance Biotherapeutics
IOVA
$2.69B
| $291K | 0.03% |
39,534
-300
| -0.8% | -$1.91K |
|
449
Pentair
PNR
$11.2B
| $290K | 0.03% |
6,495
+335
| +5% | +$14.6K |
|
450
Alcoa
AA
$13.2B
| $287K | 0.03% |
8,803
-8,197
| -48% | -$266K |
|
Similar funds
PFBT
CCP
SP
HCS
SPC
GPCM
MCM
MDSL
Prelude Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Prelude Capital Management held 2,111 positions worth $1.06B, up 1.1% from $1.05B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Prelude Capital Management withdrew a net $39M in Q2 2017, closing 537 positions and reducing 467 holdings. Its most notable exit was The WhiteWave Foods Company, an estimated $13.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 11% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Prelude Capital Management opened a new position in Altaba Inc worth $16.4M.
- Prelude Capital Management's largest Q2 2017 buy was Altaba Inc: 301,001 shares worth $16.4M.
- Prelude Capital Management added most to CR Bard Inc. in Q2 2017, an estimated $24.5M increase.
- Prelude Capital Management's biggest Q2 2017 reduction was T-Mobile US, cutting an estimated $9.34M.
- Prelude Capital Management fully exited The WhiteWave Foods Company in Q2 2017, selling an estimated $13.3M.
- Prelude Capital Management's ten largest holdings make up 18% of its $1.06B portfolio in Q2 2017.
- Prelude Capital Management opened 638 new positions and closed 537 in Q2 2017.
- Prelude Capital Management's portfolio value rose 1.1% quarter-over-quarter to $1.06B.
Based on Prelude Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.